NASDAQ:SPRO
Spero Therapeutics
- Stock
Last Close
1.37
30/08 20:00
Market Cap
73.42M
Beta: 0.87
Volume Today
58.38K
Avg: 603.93K
PE Ratio
−115.83
PFCF: 2.64
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -2.39M - | -6.77M 183.94% | -11.07M 63.47% | -12.80M 15.64% | -6.12M 52.21% | -2.23M 63.53% | -2.23M 0% | |||
average payables | 1.47M - | 2.30M 57.14% | 3.54M 53.46% | 3.88M 9.57% | 2.65M 31.59% | 1.13M 57.45% | 859K 23.85% | 997.50K 16.12% | ||
average receivables | 157K - | 1.62M 934.08% | 2.12M 30.61% | 4.92M 132.12% | 7.36M 49.55% | 4.41M 40.11% | 1.86M 57.75% | 25.89M 1,290.09% | ||
book value per share | 0.03 - | 1.54 5,088.27% | 32.84 2,033.08% | 7.24 77.95% | 4.11 43.28% | 5.90 43.64% | 2.86 51.55% | 2.02 29.30% | 2.02 0.15% | |
capex per share | -0.04 - | -0.13 257.76% | -0.01 91.69% | -0.15 1,358.54% | -0.02 88.64% | -0.01 59.44% | 0.00 118.00% | |||
capex to depreciation | -21.09 - | -2.97 85.89% | -0.07 97.50% | -5.96 7,907.50% | -0.42 92.97% | -0.21 50.72% | 0.06 129.26% | |||
capex to operating cash flow | 0.02 - | 0.03 18.70% | 0.00 97.59% | 0.06 8,805.19% | 0.01 89.79% | 0.00 70.88% | -0.00 133.15% | |||
capex to revenue | -2.48 - | -0.01 99.45% | -0.61 4,402.01% | -0.07 89.22% | -0.02 74.59% | 0.00 112.70% | ||||
cash per share | 0.86 - | 1.56 81.25% | 33.74 2,060.59% | 7.21 78.62% | 4.52 37.38% | 5.67 25.48% | 4.74 16.41% | 2.90 38.74% | 1.44 50.38% | |
days of inventory on hand | ||||||||||
days payables outstanding | 1.37K - | |||||||||
days sales outstanding | 331.22 - | 542.80 63.88% | 119.46 77.99% | 657.80 450.65% | 241.61 63.27% | 52.80 78.15% | 8.14 84.58% | 191.29 2,248.65% | ||
debt to assets | 0.10 - | 0.05 - | 0.05 2.26% | 0.04 16.06% | 0.05 24.22% | 0.03 42.94% | ||||
debt to equity | 3.73 - | 0.07 - | 0.06 20.17% | 0.08 39.96% | 0.09 5.36% | 0.05 40.76% | ||||
dividend yield | ||||||||||
earnings yield | -0.13 - | -0.34 151.04% | -1.52 351.89% | -0.42 72.09% | -0.34 18.64% | -0.18 48.15% | -0.18 3.36% | -0.74 300.17% | 0.29 139.64% | |
enterprise value | 70.26M - | 65.64M 6.58% | -56.89M 186.67% | 64.33M 213.08% | 150.52M 133.98% | 356.70M 136.98% | 389.39M 9.17% | -37.44M 109.61% | 7.10M 118.98% | |
enterprise value over ebitda | -5.21 - | -1.96 62.41% | 1.36 169.62% | -1.50 210.23% | -2.38 58.43% | -4.51 89.36% | -4.46 1.16% | 1.98 144.36% | 0.35 82.13% | |
ev to operating cash flow | -7.31 - | -2.27 69.01% | 1.45 164.18% | -1.62 211.61% | -3.01 85.35% | -4.15 38.04% | -6.05 45.68% | 4.84 180.02% | -0.22 104.45% | |
ev to sales | 195.94 - | -28.75 114.67% | 16.22 156.42% | 31.74 95.69% | 38.23 20.44% | 21.33 44.21% | -0.77 103.61% | 0.07 109.53% | ||
free cash flow per share | -1.49 - | -4.51 202.73% | -15.13 235.45% | -2.63 82.63% | -2.77 5.44% | -3.84 38.65% | -2.08 45.84% | -0.21 90.12% | -0.62 202.72% | |
free cash flow yield | -0.13 - | -0.39 202.73% | -1.29 228.31% | -0.43 66.81% | -0.29 32.59% | -0.20 31.21% | -0.13 34.40% | -0.12 8.55% | -0.42 256.26% | |
graham net net | -0.26 - | 0.47 280.57% | 30.38 6,306.49% | 6.18 79.66% | 2.77 55.23% | 4.65 67.94% | 2.12 54.30% | 1.56 26.29% | 0.73 53.14% | |
graham number | 1.01 - | 11.56 1,041.26% | 114.75 892.41% | 20.59 82.05% | 17.50 15.04% | 21.44 22.52% | 13.78 35.70% | 7.62 44.71% | 4.42 42.01% | |
income quality | 0.73 - | 0.89 21.45% | 0.98 10.52% | 0.95 3.00% | 0.82 13.68% | 1.10 33.61% | 0.72 34.65% | 0.17 76.77% | -1.45 968.60% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -137.72 - | -141.27 2.58% | -45.35 - | -16.20 64.28% | ||||||
interest debt per share | 0.11 - | 0.12 - | 0.02 83.83% | 0.31 1,512.50% | 0.35 14.67% | 0.30 14.26% | 0.25 18.00% | 0.10 57.50% | ||
inventory turnover | ||||||||||
invested capital | 3.73 - | 0.07 - | 0.06 20.17% | 0.08 39.96% | 0.09 5.36% | 0.05 40.76% | ||||
market cap | 75.96M - | 75.96M 0% | 30.40M 59.98% | 98.41M 223.77% | 174.70M 77.52% | 434.07M 148.46% | 494.64M 13.96% | 65.02M 86.85% | 77.89M 19.80% | |
net current asset value | -1.45M - | 4.46M 408.72% | 78.77M 1,665.66% | 102.29M 29.87% | 50.52M 50.62% | 105.50M 108.83% | 75.09M 28.82% | 60.24M 19.78% | 55.71M 7.52% | |
net debt to ebitda | 0.42 - | 0.31 27.06% | 2.09 579.78% | 0.80 61.94% | 0.38 51.95% | 0.98 155.63% | 1.20 23.17% | 5.41 349.17% | -3.52 165.07% | |
net income per share | -1.54 - | -3.86 151.04% | -17.82 361.71% | -2.60 85.39% | -3.31 27.27% | -3.46 4.51% | -2.96 14.66% | -1.28 56.76% | 0.43 133.68% | |
operating cash flow per share | -1.45 - | -4.38 201.41% | -15.12 244.83% | -2.48 83.62% | -2.75 11.23% | -3.84 39.27% | -2.08 45.71% | -0.21 90.12% | -0.62 202.72% | |
payables turnover | 0.27 - | |||||||||
receivables turnover | 1.10 - | 0.67 38.98% | 3.06 354.38% | 0.55 81.84% | 1.51 172.25% | 6.91 357.58% | 44.81 548.31% | 1.91 95.74% | ||
research and ddevelopement to revenue | 78.61 - | 16.61 78.87% | 8.54 48.56% | 13.87 62.35% | 7.18 48.23% | 3.53 50.78% | 0.98 72.28% | 0.53 46.11% | ||
return on tangible assets | -1.41 - | -1.85 30.81% | -0.49 73.36% | -0.32 34.51% | -0.57 75.61% | -0.51 10.93% | -0.53 5.65% | -0.38 27.89% | 0.13 132.49% | |
revenue per share | 0.05 - | 0.77 1,408.30% | 0.25 67.60% | 0.26 5.35% | 0.42 59.61% | 0.59 41.78% | 1.29 118.74% | 1.83 41.24% | ||
roe | -51.81 - | -2.51 95.16% | -0.54 78.35% | -0.36 33.72% | -0.81 124.39% | -0.59 27.24% | -1.03 76.14% | -0.63 38.84% | 0.21 133.73% | |
roic | -10.91 - | -2.49 77.14% | -0.49 80.45% | -0.38 22.10% | -0.73 92.00% | -0.53 27.23% | -0.87 63.87% | -0.49 43.70% | 0.15 131.15% | |
sales general and administrative to revenue | 21.56 - | 5.48 74.60% | 3.25 40.68% | 3.29 1.16% | 2.30 30.09% | 2.28 0.60% | 0.75 67.12% | 0.26 64.83% | ||
shareholders equity per share | 0.03 - | 1.54 5,088.27% | 32.84 2,033.08% | 7.24 77.95% | 4.11 43.28% | 5.90 43.64% | 2.86 51.55% | 2.02 29.30% | 2.02 0.15% | |
stock based compensation to revenue | 0.54 - | 0.72 34.20% | 0.69 3.87% | 0.80 14.88% | 0.52 34.21% | 0.52 1.40% | 0.19 63.64% | 0.08 56.34% | ||
tangible asset value | -257K - | 6.36M 2,575.10% | 84.96M 1,235.59% | 115.86M 36.37% | 74.57M 35.63% | 132.04M 77.06% | 88.29M 33.13% | 75.93M 13.99% | 106.89M 40.77% | |
tangible book value per share | -0.04 - | 0.96 2,575.10% | 32.84 3,310.05% | 7.24 77.95% | 4.11 43.28% | 5.90 43.64% | 2.86 51.55% | 2.02 29.30% | 2.02 0.15% | |
working capital | -433K - | 4.95M 1,244.11% | 79.13M 1,497.32% | 103.13M 30.32% | 55.38M 46.30% | 112.56M 103.25% | 139.20M 23.67% | 87.46M 37.17% | 94.06M 7.54% |
All numbers in USD (except ratios and percentages)